We are routinely applying and constantly improving protein analysis techniques, including proteome profiling as well as accurate targeted quantification methods. While we are focussing on human proteins involved in inflammation and cancer, we also deal with proteins from animal model systems, microorganisms and plants. Furthermore, we are identifying and quantifying biologically relevant lipids such as eicosanoids and metabolites such as melatonin.

Thus, our main aims are the establishment and application of powerful screening and targeted analytical assays which allow us to better understand disease mechanism, improve drug effects, to design novel drug combinations and to monitor treatment effects. It is our vision to apply such analytical assays in pharmacological and clinical studies performed in collaboration with medical research partners in order to monitor the effects of treatments and to adapt applied therapies in an individualized fashion.